GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OTCPK:OASMY) » Definitions » 3-Year FCF Growth Rate

OASMY (Vivesto AB) 3-Year FCF Growth Rate : 39.70% (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Vivesto AB 3-Year FCF Growth Rate?

Vivesto AB's Free Cash Flow per Share for the three months ended in Mar. 2025 was $-0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 39.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 12.20% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 22.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Vivesto AB was 60.70% per year. The lowest was -97.30% per year. And the median was 11.25% per year.


Competitive Comparison of Vivesto AB's 3-Year FCF Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Vivesto AB's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivesto AB's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivesto AB's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Vivesto AB's 3-Year FCF Growth Rate falls into.


;
;

Vivesto AB 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Vivesto AB  (OTCPK:OASMY) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Vivesto AB 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Vivesto AB's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivesto AB Business Description

Traded in Other Exchanges
Address
Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.

Vivesto AB Headlines

From GuruFocus

Q3 2022 Vivesto AB Earnings Call Transcript

By GuruFocus Research 03-06-2024

Oasmia Pharmaceutical AB Online Presentation Transcript

By GuruFocus Research 03-06-2024

Q1 2021 Oasmia Pharmaceutical AB Earnings Call Transcript

By GuruFocus Research 03-06-2024

Oasmia Pharmaceutical AB (publ) - Special Call Transcript

By GuruFocus Research 03-06-2024